ABSTRACT
Cobalt(II) and nickel(II) complexes of the antibacterial drug Ceclor have been synthesized and characterized on the basis of their elemental analysis, molar conductance, magnetic moment and electronic and infrared spectral data. These complex have been, then subjected to screening for their antibacterial properties against bacterial species such as Streptococcus pyogenes, Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli. In comparison to uncomplexed Ceclor, the metal complexes have been shown to be more antibacterial.
Subject(s)
Anti-Bacterial Agents/chemical synthesis , Bacteria/drug effects , Cefaclor/analogs & derivatives , Cefaclor/pharmacology , Cobalt/pharmacology , Nickel/pharmacology , Anti-Bacterial Agents/pharmacology , Cefaclor/chemistry , Cobalt/chemistry , Microbial Sensitivity Tests , Nickel/chemistryABSTRACT
Some (alpha-hydrazinobenzyl)cephalosporins, I (R = Me, CH2OAc, Cl) and II (R = Me, CH2OAc), structurally related (formula; see text) to cephalexin, cephaloglycin, and cefaclor have been prepared and evaluated in vitro for their antimicrobial activity. The synthesis involves the condensation of the chloride hydrochloride III (R = H or Me) with the 7-aminocephem derivatives IV. The hydrazino compound I (R = Cl), an analogue of cefaclor, resulted in being the most active compound of the series.